Financial News
Akbank T/A/S ADR (OP:AKBTY)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 2.830 |
| Bid (Size) | N/A (0) |
| Ask (Size) | N/A (0) |
| Prev. Close | 2.830 |
| Today's Range | 2.830 - 2.830 |
| 52wk Range | 2.530 - 4.240 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
OTC Markets Group Announces the 2025 OTCQX Best 50
January 15, 2025
Performance
52-Week Range
33.3% below 52-week high
2.830
2.5352W Low
4.2452W High
1 Week
1.0% below 1-week high
2.551W Low
2.861W High
Akbank T/A/S ADR (AKBTY) traded between $2.53 and $4.24 over the past 52 weeks and last traded at $2.83, 33.3% below its 52-week high. Over the past week it ranged between $2.55 and $2.86.
Past 12 Months
1W
+$0.12
1M
-$0.16
3M
-$0.03
6M
-$0.68
YTD
-$0.46
1Y
+$0.12
AKBTY was +4.4% over the past year, -19.3% over six months, -14.0% year to date, +4.4% in the last week.
12 Months vs Market
AKBTY
+4.4%
DIA
+12.5%
SPY
+15.2%
QQQ
+18.6%
IWM
+11.9%
Over the past 12 months AKBTY returned +4.4% versus DIA (Dow) +12.5%, SPY (S&P 500) +15.2%, QQQ (Nasdaq 100) +18.6% and IWM (Russell 2000) +11.9%.
Volume & Liquidity
1W
7.8K
1M
7.2K
3M
10.3K
6M
15.5K
YTD
14.1K
1Y
14.1K
AKBTY's 3-month average daily volume is 10.3K.
Frequently Asked Questions
Is Akbank T/A/S ADR publicly traded?
Yes, Akbank T/A/S ADR is publicly traded.
What exchange does Akbank T/A/S ADR trade on?
Akbank T/A/S ADR trades on the OTC Traded
What is the ticker symbol for Akbank T/A/S ADR?
The ticker symbol for Akbank T/A/S ADR is AKBTY on the OTC Traded
What is the current price of Akbank T/A/S ADR?
The current price of Akbank T/A/S ADR is 2.830
When was Akbank T/A/S ADR last traded?
The last trade of Akbank T/A/S ADR was at 10/21/26 03:54 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
